1.
Gmizic II, Barac A, Todorovic N, Sabanovic M, Kekic N, Boskovic N, Vujovic A, Nikolic N, Knezevic N, Milosevic I, Stevanovic G (2024) Molnupiravir’s real-world effectiveness in COVID-19 outpatients at high risk of severe disease: a single-center study. J Infect Dev Ctries 18:694–700. doi: 10.3855/jidc.18802